122 related articles for article (PubMed ID: 15801855)
1. Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists.
Di Stefano A; Sozio P; Cacciatore I; Cocco A; Giorgioni G; Costa B; Montali M; Lucacchini A; Martini C; Spoto G; Di Pietrantonio F; Di Matteo E; Pinnen F
J Med Chem; 2005 Apr; 48(7):2646-54. PubMed ID: 15801855
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands.
Di Stefano A; Sozio P; Luisi G; Cacciatore I; Mosciatti B; Costa B; Lucacchini A; Martini C; Pinnen F
Farmaco; 2002 Apr; 57(4):303-13. PubMed ID: 11989809
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, resolution, and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptors ligands.
Claudi F; Cingolani GM; Di Stefano A; Giorgioni G; Amenta F; Barili P; Ferrari F; Giuliani D
J Med Chem; 1996 Oct; 39(21):4238-46. PubMed ID: 8863801
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of N-n-propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine derivatives as dopamine receptor ligands.
Claudi F; Giorgioni G; Di Stefano A; Renò F; Balduini W
Drug Des Discov; 1992; 9(2):155-66. PubMed ID: 1296798
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
6. New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor.
Macchia M; Cervetto L; Demontis GC; Longoni B; Minutolo F; Orlandini E; Ortore G; Papi C; Sbrana A; Macchia B
J Med Chem; 2003 Jan; 46(1):161-8. PubMed ID: 12502370
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
10. N-n-Propyl-substituted 3-(dimethylphenyl)piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and receptor binding studies.
Cervetto L; Demontis GC; Giannaccini G; Longoni B; Macchia B; Macchia M; Martinelli A; Orlandini E
J Med Chem; 1998 Dec; 41(25):4933-8. PubMed ID: 9836610
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
[TBL] [Abstract][Full Text] [Related]
12. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands.
Claudi F; Di Stefano A; Napolitani F; Cingolani GM; Giorgioni G; Fontenla JA; Montenegro GY; Rivas ME; Rosa E; Michelotto B; Orlando G; Brunetti L
J Med Chem; 2000 Feb; 43(4):599-608. PubMed ID: 10691686
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
Doll MK; Nichols DE; Kilts JD; Prioleau C; Lawler CP; Lewis MM; Mailman RB
J Med Chem; 1999 Mar; 42(5):935-40. PubMed ID: 10072690
[TBL] [Abstract][Full Text] [Related]
14. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.
Grubbs RA; Lewis MM; Owens-Vance C; Gay EA; Jassen AK; Mailman RB; Nichols DE
Bioorg Med Chem; 2004 Mar; 12(6):1403-12. PubMed ID: 15018913
[TBL] [Abstract][Full Text] [Related]
15. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of N-n-propyl-N-(2-arylethyl)-5-(1H-benzimidazol-2-thione)-eth ylamines and related compounds as potential dopaminergic ligands.
Soskic V; Dukić S; Dragović D; Joksimović J
Arzneimittelforschung; 1996 Aug; 46(8):741-6. PubMed ID: 9125270
[TBL] [Abstract][Full Text] [Related]
17. Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease.
McCall RB; Lookingland KJ; Bédard PJ; Huff RM
J Pharmacol Exp Ther; 2005 Sep; 314(3):1248-56. PubMed ID: 15980060
[TBL] [Abstract][Full Text] [Related]
18. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
19. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
Ryman-Rasmussen JP; Nichols DE; Mailman RB
Mol Pharmacol; 2005 Oct; 68(4):1039-48. PubMed ID: 15985612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
